Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma

Name: Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma
License: Public Domain

Lei Zheng

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

resectable pancreatic ductal adenocarcinoma (pdac), pancreatic ductal adenocarcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 353294
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.